http://www.zibb.com/healthcare/theme/cq/Acusphere,+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Tue, 24 Nov 2009 09:10:40 GMTTue, 24 Nov 2009 09:10:40 GMT608831http://www.zibb.com/healthcare/theme/cq/Acusphere,+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.acusphere.com/7-02-02.htmlWatertown, MA, July 2, 2002 Acusphere, Inc. announced today the issuance of U.S. Patent No. 6,395,300, entitled "Porous Drug Matrices and Methods of Manufacture Thereof.http://www.acusphere.com/7-02-02.htmlAcusphere, Incorporatedhttp://www.apria.com/resources/1,2725,494-874329,00.htmlAcusphere, Inc. (NASDAQ: ACUS) announced that Dr. Richard Walovitch, Senior Vice President of Clinical Research, has resigned to pursue another opportunity.http://www.apria.com/resources/1,2725,494-874329,00.htmlAcusphere, Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=188878th US-Japan Symposium on Drug Delivery Systems WATERTOWN, Mass.--(BUSINESS WIRE)--Dec. 21, 2005--Acusphere, Inc. (NASDAQ:ACUS) today announced today that Dr.http://www.pharmacychoice.com/News/article.cfm?Article_ID=18887Acusphere, Incorporatedhttp://www.polarisventures.com/Portfolio/CompanyDetail.asp?CompanyID={5082A095-A433-453F-AFB6-A37D2BB7A40F}Acusphere (NASDAQ: ACUS) is a specialty pharmaceuticals company that develops new drugs and improved formulations of existing drugs using its propriety porous microparticle technology.http://www.polarisventures.com/Portfolio/CompanyDetail.asp?CompanyID={5082A095-A433-453F-AFB6-A37D2BB7A40F}Acusphere, Incorporatedhttp://www.nycomed.com/nycomed/helpers/resourceimage.aspx?guid=1EF2E0F7-C4C4-43F9-A8D4-4AC74778283CNycomed Group Langebjerg 1 Telephone: Internet: Corporate Communications PO Box 88 (+45) 46 77 11 11 www.nycomed.com 4000 Roskilde Telefax: Denmark (+45) 46 77 42 72 Nycomed announces USD70 million European marketing agreementhttp://www.nycomed.com/nycomed/helpers/resourceimage.aspx?guid=1EF2E0F7-C4C4-43F9-A8D4-4AC74778283CAcusphere, Incorporatedhttp://www.lumisys.com/index.asp?sec=sup&sub=car&pag=dis&itemid=78515Become a Cardiac Imaging Insider! When AuntMinnie gets hot new information on Cardiac Imaging, Cardiac Imaging Insiders are the first to find out. Receive exclusive e-mail updates on your favorite new technologies and get techniques for staying current in today's competitive radiology market.http://www.lumisys.com/index.asp?sec=sup&sub=car&pag=dis&itemid=78515Acusphere, Incorporatedhttp://www.micromedex.com/pressroom/news_feeds/?story_ID=95655&category=16Get the news that matters to you. Create your own customized news service that delivers the latest information directly to you. Plus you can view the most current press releases from Micromedex.http://www.micromedex.com/pressroom/news_feeds/?story_ID=95655&category=16Acusphere, Incorporatedhttp://www.acusphere.com/directions.htmlFrom Logan Airport: Exit airport and follow signs to Tunnel (Pay $2 toll). At end of tunnel, get onto Route 93 North for about 1/4 mile, then take 1st exit, Exit 26 to Storrow Drive. Stay on Storrow Drive, which becomes Soldiers Field Road. Take the ramp towards Central SQ./MASS. PIKE (I-90).http://www.acusphere.com/directions.htmlAcusphere, Incorporatedhttp://www.acusphere.com/articles_sh.htmlThe articles provided herein are provided for the convenience of current and perspective Acusphere investors and employees. The product candidates described in these documents are not approved for marketing or sale. Many of the authors of these articles are independent of Acusphere.http://www.acusphere.com/articles_sh.htmlAcusphere, Incorporatedhttp://www.acusphere.com/jobs.htmlAcusphere is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using our proprietary porous microparticle technology.http://www.acusphere.com/jobs.htmlAcusphere, Incorporatedhttp://www.acusphere.com/9-11-03.htmWatertown, MA, September 11, 2003 Acusphere, Inc. today announced the appointment of Charles P. Cox, Ph.D. as Senior Vice President, Corporate Development and Marketing. Dr. Cox brings to Acusphere more than 10 years of senior management experience in the specialty pharmaceutical industry.http://www.acusphere.com/9-11-03.htmAcusphere, Incorporatedhttp://www.acusphere.com/terms.htmlPlease read these terms carefully before using this Web site. These materials are provided by Acusphere, Inc. ("Acusphere" or the "Company") for informational purposes only. Single copies may be downloaded subject to the provisions below.http://www.acusphere.com/terms.htmlAcusphere, Incorporatedhttp://www.acusphere.com/7-24-02.htmlWatertown, MA, July 24, 2002 Acusphere, Inc., a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary porous microparticle technology, announced today that it has completed a $15 million round of financing.http://www.acusphere.com/7-24-02.htmlAcusphere, Incorporatedhttp://www.acusphere.com/management.htmlSherri C. Oberg, a co-founder of Acusphere, has served as our President and Chief Executive Officer and one of our directors since our inception in 1993. Prior to joining Acusphere, Ms. Oberg was President and Chief Executive Officer of Neomorphics, Inc.http://www.acusphere.com/management.htmlAcusphere, Incorporatedhttp://www.acusphere.com/10-7-02.htmAI-SR is Acusphere's novel, dry powder sustained release, microparticle formulation of a leading asthma drug. It is designed to slowly release the asthma drug locally in the lungs and thereby reduce the multi-dosing daily regimen to a once per day treatment.http://www.acusphere.com/10-7-02.htmAcusphere, Incorporatedhttp://www.acusphere.com/12-18-03.htmWatertown, MA, December 18, 2003 - Acusphere, Inc. (NASDAQ: ACUS), today reported that it has commenced the pivotal phase of its Phase 3 clinical program for AI-700, an ultrasound contrast agent designed for detecting coronary artery disease.http://www.acusphere.com/12-18-03.htmAcusphere, Incorporatedhttp://www.acusphere.com/contact.htmlContact Us Mailing address: Acusphere, Inc. 500 Arsenal Street Watertown, MA 02472 Headquarters: Acusphere, Inc. 500 Arsenal Street Watertown, MA 02472 617.648.8800 phone 617.926.4750 fax Driving directions, public transportation directions, and map to our Watertown facility Satellite Office:http://www.acusphere.com/contact.htmlAcusphere, Incorporatedhttp://www.acusphere.com/9-18-02.htmWatertown, MA, September 18, 2002 Acusphere, Inc. announced today the issuance of U.S. Patent No. 6,423,345, entitled "Matrices Formed of Polymer and Hydrophobic Compounds for Use in Drug Delivery".http://www.acusphere.com/9-18-02.htmAcusphere, Incorporatedhttp://www.acusphere.com/10-7-03.htmWATERTOWN, Mass.--(BUSINESS WIRE)--Oct. 7, 2003--Acusphere, Inc. (NASDAQ: "ACUS") today announced the pricing of its initial public offering of 3,750,000 shares of its common stock at $14.00 per share, before underwriting discounts and commissions.http://www.acusphere.com/10-7-03.htmAcusphere, Incorporatedhttp://www.apria.com/resources/1,2725,494-857840,00.htmlWATERTOWN, Mass., Dec 10, 2008 (BUSINESS WIRE) -- Acusphere, Inc. (NASDAQ: ACUS) today announced that NASDAQ has halted trading in the Company's common stock today. The Cardio Renal Advisory Committee to the U.S.http://www.apria.com/resources/1,2725,494-857840,00.htmlAcusphere, Incorporatedhttp://www.apria.com/resources/1,2725,494-869663,00.htmlWATERTOWN, Mass., Jan 07, 2009 (BUSINESS WIRE) -- Acusphere, Inc. (NASDAQ: ACUS) today announced that Dr. Richard Walovitch, Senior Vice President of Clinical Research, has resigned to pursue another opportunity.http://www.apria.com/resources/1,2725,494-869663,00.htmlAcusphere, Incorporatedhttp://www.apria.com/resources/1,2725,494-876576,00.htmlThe paper concludes that Imagify Perfusion Stress Echo is well-tolerated, and that its diagnostic performance in chest pain patients is comparable with single photo emission computed tomography, or SPECT, perfusion imaging.http://www.apria.com/resources/1,2725,494-876576,00.htmlAcusphere, Incorporatedhttp://www.apria.com/resources/1,2725,494-858187,00.htmlWATERTOWN, Mass., Dec 10, 2008 (BUSINESS WIRE) -- Acusphere, Inc. (NASDAQ: ACUS) today announced that the Cardiovascular and Renal Drugs Advisory Committee of the U.S.http://www.apria.com/resources/1,2725,494-858187,00.htmlAcusphere, Incorporatedhttp://www.apria.com/resources/1,2725,494-858193,00.htmlSILVER SPRING, Md., Dec 10 (Reuters) - A U.S. Food and Drug Administration advisory panel rejected Acusphere Inc's imaging contrast agent on Wednesday, saying possible risks outweighed its potential for screening heart patients.http://www.apria.com/resources/1,2725,494-858193,00.htmlAcusphere, Incorporatedhttp://www.apria.com/resources/1,2725,494-858192,00.htmlA U.S. Food and Drug Administration advisory panel rejected Acusphere Inc's imaging contrast agent on Wednesday, saying possible risks outweighed its potential for screening heart patients.http://www.apria.com/resources/1,2725,494-858192,00.htmlAcusphere, Incorporated